Yoga Sessions
BehavioralParticipants will have up to 12 sessions, 3 sessions per week starting two weeks before the transplant and throughout the first 30 days of your hospitalization.
NCT Number: NCT05681026
To develop and measure the effects of a culturally sensitive yoga program for inpatients
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Swami Vivekananda Yoga Anusandhana Samsthana, Giddenahalli, Karnataka, India
Primary Objective:
Secondary Objectives:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will have up to 12 sessions, 3 sessions per week starting two weeks before the transplant and throughout the first 30 days of your hospitalization.
Participants will complete 4 questionnaires about any symptoms you may be having, any anxiety and/or depression you may be having, your quality of life, and your expectations about your treatment.
Participants will have an exit interview last about 30-45 minutes. The interview will be conducted over the phone or remotely over Zoom, FaceTime, or other approved video call methods.). The interview will be audio and video recorded and transcribed (typed).
Time frame: through study completion; an average of 1 year
The PHQ-8 is a 8-item self-report questionnaire used to assess bother of depressive symptoms over the past 2 weeks. The PHQ-8 is a 8-item questionnaire to screen for degree of depressive symptoms scored on a 0-24 scale with higher scores indicating greater distress and impairment
Contact information is provided by the study sponsor or research team.
M.D. Anderson Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06564233
Cancer, Hematopoietic Stem Cell Transplantation
Boston, Massachusetts, United States
View Trial DetailsNCT07391046
Asplenia, Autoimmune Diseases
View Trial DetailsNCT00888316
Allogeneic Hematopoietic Cell Transplantation, Cancer
Minneapolis, Minnesota, United States
View Trial DetailsNCT01061801
Cancer, Hematopoietic Stem Cell Transplantation
Seattle, Washington, United States
View Trial Details